Friday, November 16, 2012 4:56:44 PM
Only one, KR, benefits from this low volume when he is out searching for investors. He needs to establish a higher market price, we have moved from $.09 cents a share to $.22 with no news and no filings and no rumors. But remember before the RS this $.22 price represents a $.00073 price. With the proxy vote to increase the authorized to 200 million, that would represent a before RS authorized level at 60 billion shares.
With the history here of reverse splits, you can bet folks have been doing the math of how many shares common stock holders have lost investing in KR’s private offerings and open market purchases.
With the authorized still filed with Nevada still at 3.33 million, even with the reported vote, the company needs to file the change with the state which they still haven’t done.
Also remember the series “A” preferred shares KR gave himself. I don’t think KR has the personal funds to pay out in damages, maybe folks are looking at the other parties to the transactions and benefits received for looking the other way.
It is like waiting for more fuel to be added to the fire.
Recent GRVE News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 10:09:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/11/2024 08:30:14 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 11/06/2023 08:29:45 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 10/20/2023 01:54:27 AM
- Form 10-12G - Registration of securities [Section 12(g)] • Edgar (US Regulatory) • 09/14/2023 09:17:05 PM
- Form RW - Registration Withdrawal Request • Edgar (US Regulatory) • 08/14/2023 09:15:56 PM
- Form 10-12G/A - Registration of securities [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/25/2023 07:29:23 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM